- Report
- September 2024
- 371 Pages
Global
From €4706EUR$4,950USD£3,953GBP
- Report
- April 2024
- 180 Pages
Global
From €4235EUR$4,455USD£3,558GBP
€4706EUR$4,950USD£3,953GBP
- Report
- August 2024
- 260 Pages
Global
From €5276EUR$5,550USD£4,432GBP
- Report
- October 2024
- 186 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- July 2024
- 147 Pages
Global
From €2851EUR$2,999USD£2,395GBP
- Report
- March 2025
- 89 Pages
Global
From €5324EUR$5,600USD£4,472GBP
- Report
- July 2024
- 190 Pages
Global
From €2177EUR$2,290USD£1,829GBP
- Report
- July 2024
- 100 Pages
Global
From €3565EUR$3,750USD£2,995GBP
- Report
- November 2024
- 68 Pages
Asia Pacific
From €2781EUR$2,925USD£2,336GBP
€3090EUR$3,250USD£2,596GBP
- Report
- November 2024
- 78 Pages
Europe
From €2781EUR$2,925USD£2,336GBP
€3090EUR$3,250USD£2,596GBP
- Report
- January 2025
- 160 Pages
United States
From €1995EUR$2,099USD£1,676GBP
€2851EUR$2,999USD£2,395GBP
- Report
- February 2025
Global
From €4658EUR$4,900USD£3,913GBP
- Report
- April 2024
- 134 Pages
Global
From €4421EUR$4,650USD£3,714GBP
- Report
- January 2025
- 150 Pages
Global
From €4421EUR$4,650USD£3,714GBP
- Report
- March 2025
- 141 Pages
Global
From €2851EUR$2,999USD£2,395GBP
- Report
- February 2025
- 194 Pages
Global
From €5181EUR$5,450USD£4,353GBP
- Report
- March 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- October 2024
- 181 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- May 2024
- 90 Pages
United States
From €3327EUR$3,500USD£2,795GBP

Non-invasive prenatal testing (NIPT) is a type of prenatal screening used to detect chromosomal abnormalities in a fetus. It is a safe and accurate method of testing that does not involve any risk to the mother or fetus. NIPT is typically used to detect Down syndrome, trisomy 18, and trisomy 13, as well as other chromosomal abnormalities. It is also used to determine the sex of the fetus. NIPT is becoming increasingly popular as an alternative to traditional invasive prenatal testing, such as amniocentesis and chorionic villus sampling.
NIPT is offered by a variety of diagnostic companies, including Illumina, Natera, Ariosa Diagnostics, and Sequenom. These companies provide a range of services, from laboratory testing to genetic counseling. They also offer a variety of testing options, such as single-gene tests, whole-genome sequencing, and targeted sequencing. Show Less Read more